药学学报2024,Vol.59Issue(2) :404-412.DOI:10.16438/j.0513-4870.2023-1136

不同母核结构苦豆碱衍生物合成及其抗冠状病毒活性研究

Synthesis and evaluation for anti-HCoV-OC43 activity of novel aloperine derivatives with different core structures

孟润泽 公玥 施宇龙 王坤 彭宗根 宋丹青
药学学报2024,Vol.59Issue(2) :404-412.DOI:10.16438/j.0513-4870.2023-1136

不同母核结构苦豆碱衍生物合成及其抗冠状病毒活性研究

Synthesis and evaluation for anti-HCoV-OC43 activity of novel aloperine derivatives with different core structures

孟润泽 1公玥 1施宇龙 1王坤 1彭宗根 1宋丹青1
扫码查看

作者信息

  • 1. 中国医学科学院、北京协和医学院医药生物技术研究所,北京 100050
  • 折叠

摘要

本研究设计合成了不同母核结构的12个全新苦豆碱衍生物,其中十元大环骨架苦豆碱衍生物3通过季铵盐γ-H的霍夫曼消除后扩环获得,结构经X-单晶确证.进而采用CCK-8法评价了目标物对抗人类β-冠状病毒HCoV-OC43的活性.结果显示,季铵盐苦豆碱2a与化合物3均具有良好活性,2a表现出最好抗病毒活性,EC5.值为3.77 μmol·L-1,SI值大于53.1.Schrödinger分子对接结果显示,化合物2a与3均可能通过直接靶向宿主TMPRSS2和SR-B1发挥抗冠状病毒作用.研究结果拓展了桥环骨架苦豆碱的结构类型及其抗冠状病毒用途,为发展一类新型抗冠状病毒化合物提供了有益科学数据.

Abstract

In this study,we designed and synthesized 12 novel aloperine derivatives with different core struc-tures.Among them,compound 3 with a ten-membered ring core was obtained through a special ring expansion reaction after y-H Huffman elimination of quaternary ammonium salt,and the structure was verified by X-single crystal diffraction.Furthermore,their antiviral activity against human β-coronavirus HCoV-OC43 was evaluated by CCK-8 assay.Quaternary ammonium salt 2a and 3 had a good inhibitory effect against HCoV-OC43,and 2a had the highest anti-HCoV-OC43 activity with an EC50 values of 3.77 μmol·L-1 and a SI value of over 53.1.Schrödinger molecular docking results showed that both 2a and 3 might display their anti-HCoV-OC43 activity by directly acting on host TMPRSS2 and SR-B1.The results expanded the structural types of endocyclic aloperine and the function against coronavirus,and provided useful scientific data for the development of pharmaceutical applica-tions of these compounds.

关键词

季铵盐苦豆碱/新型冠状病毒/十元环苦豆碱/TMPRSS2/SR-B1

Key words

quaternary ammonium salt aloperine/SARS-CoV-2/ten-membered ring aloperine/TMPRSS2/SR-B1

引用本文复制引用

基金项目

国家自然科学基金(81974494)

中国医科院医学与健康科技创新工程项目(2021-I2M-1-048)

出版年

2024
药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
参考文献量13
段落导航相关论文